Celularity Inc.
CELU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,284 | $5,736 | $11,426 | $18,132 |
| % Growth | -7.9% | -49.8% | -37% | – |
| Cost of Goods Sold | $2,018 | $5,242 | $3,554 | $7,343 |
| Gross Profit | $3,266 | $494 | $7,872 | $10,789 |
| % Margin | 61.8% | 8.6% | 68.9% | 59.5% |
| R&D Expenses | $4,598 | $3,352 | $3,728 | $3,828 |
| G&A Expenses | $0 | $0 | $0 | $16,035 |
| SG&A Expenses | $9,306 | $12,634 | $14,262 | $16,058 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $23 |
| Other Operating Expenses | $2,262 | $372 | $368 | $183 |
| Operating Expenses | $16,166 | $16,358 | $18,358 | $20,069 |
| Operating Income | -$12,900 | -$15,864 | -$10,486 | -$9,280 |
| % Margin | -244.1% | -276.6% | -91.8% | -51.2% |
| Other Income/Exp. Net | -$10,176 | -$8,660 | -$9,268 | -$4,013 |
| Pre-Tax Income | -$23,076 | -$24,524 | -$19,754 | -$13,293 |
| Tax Expense | -$3 | $0 | $0 | $0 |
| Net Income | -$23,073 | -$24,524 | -$19,754 | -$13,293 |
| % Margin | -436.7% | -427.5% | -172.9% | -73.3% |
| EPS | -0.876 | -1.021 | -0.84 | -0.595 |
| % Growth | 14.2% | -21.6% | -41.2% | – |
| EPS Diluted | -0.876 | -1.021 | -0.84 | -0.595 |
| Weighted Avg Shares Out | 26,348 | 24,020 | 23,531 | 22,352 |
| Weighted Avg Shares Out Dil | 26,348 | 24,020 | 23,531 | 22,352 |
| Supplemental Information | – | – | – | – |
| Interest Income | $62 | $62 | $76 | $77 |
| Interest Expense | $1,477 | $1,943 | $2,437 | $1,812 |
| Depreciation & Amortization | $1,866 | $1,834 | $1,834 | $1,876 |
| EBITDA | -$19,733 | -$20,747 | -$15,483 | -$7,597 |
| % Margin | -373.4% | -361.7% | -135.5% | -41.9% |